{"url_path":"/sec/vsee/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-001883-index.html","accession_number":"0001185185-26-001883","cik":"0001864531","ticker":"VSEE","issuer_name":"VSEE HEALTH, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1864531/0001185185-26-001883-index.html","primary_entity_key":"0001864531","primary_entity_name":"VSEE HEALTH, INC."},"word_count":57,"has_tables":true,"body_markdown":"**Item 5.\nOther Information**\n\n \n\nDuring\nthe three months ended March 31, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) informed us\nof the adoption or termination of a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement”\n(as defined in Item 408 of Regulation S-K).\n\n \n\n58\n\n[Table of Contents](#TableOfContents)"}